U.S. Hemophilia Treatment Market ANALISI DIMENSIONE E QUOTA - TENDENZE DI CRESCITA E PREVISIONI (2024 - 2031)

U.S. Hemophilia Treatment Market is Segmented By Product Type (Recombinant Coagulation Factor, Plasma Derived Coagulation Factor, Antifibrinolytic Agents, and Others), By Disease Type (Hemophilia A, Hemophilia B, and Hemophilia C), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies). The report offers the value (in USD billion) for the above-mentioned segments.

U.S. Hemophilia Treatment Market Leaders

  • Takeda Farmaceutica Società Limitata
  • Sanofi Octapharma AG
  • Orfano svedese Biovitrum AB
  • Baxter Internazionale Inc.
  • Biogen Inc.
*Disclaimer: Major players are listed in no particular order.

U.S. Hemophilia Treatment Market - Company List

  • Takeda Farmaceutica Società Limitata
  • Sanofi Octapharma AG
  • Orfano svedese Biovitrum AB
  • Baxter Internazionale Inc.
  • Biogen Inc.
  • Bayer AG
  • CSL Comportamento
  • Ferring B.V.
  • Pfizer, Inc.
  • Kedrion
  • Novo Nordisk A/S
  • Grifols S.A.
  • Sangamo Therapeutics, Inc.
  • Spark Therapeutics, Inc.

U.S. Hemophilia Treatment Market Report Snapshots

Buy Now